Insulin should be considered in patients with evidence of ongoing catabolism (weight loss) or symptoms of hyperglycemia (ie, polyuria, polydipsia) and / or with HbA1C levels > 10% and blood glucose levels ≥ 300 mg / dL (16.6 mmol/L).